Answers are grounded in this paper and cite their sources.
Immunosuppressive regimens are imperative for improving patient and graft survival following kidney transplantation in patients with kidney failure. However, real-world evidence regarding treatments and outcomes in these patients is scarce. We sought to describe the treatment switches (assessed by line of treatment [LOT]), patterns, and outcomes in patients who underwent kidney transplantation in the United States.
No takes yet. Share an insight, caveat, or question.
Geissbühler et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: